The storied success of sildenafil has undeniably influenced the pharmaceutical landscape. However, wagering in companies heavily reliant on copycat drugs and the declining patent protection surrounding https://indexedbookmarks.com/story21294536/the-blue-pill-and-drugmakers-a-risky-investment